Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: DTIs for Injection
Global DTIs for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
16 Oct 2024
Pharma & Healthcare
Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.
USD3480.00
Add To Cart
Global DTIs for Injection Supply, Demand and Key Producers, 2024-2030
16 Oct 2024
Pharma & Healthcare
Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: DTIs for Injection
Total: 2 records, 1 pages
Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.
USD3480.00
Add To Cart
Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>